NCT07343596 2026-03-03
Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
University of Wisconsin, Madison
Phase NA Recruiting
Clinical Trials
5 trialsNCT07422779 2026-02-20
MAK
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT05047094 2025-12-02
A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT03769129 2024-06-25
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Second Affiliated Hospital of Guangzhou Medical University
Phase NA Recruiting
NCT06000358 2023-08-21
LUCACRIMUNO
Lithuanian University of Health Sciences
Phase NA Recruiting